NSAIDs may raise risk of kidney injury in patients with diabetes
Short-term use of NSAIDs, which include ibuprofen, aspirin and naproxen, is linked to kidney damage and high potassium levels, researchers have found.
Short-term use of NSAIDs, which include ibuprofen, aspirin and naproxen, is linked to kidney damage and high potassium levels, researchers have found.
The COVID picture at 6 months: Symptoms patients face after leaving the hospital … New CDC study confirms community link to COVID rate in residents, staff … Nurse-led intervention encourages advance care planning discussions … COVID vaccination guidelines for diabetes types are conflicting … PPIs no more helpful than placebo for gastric reflux throat symptoms,…
A clear new classification of prediabetes subtypes can help clinicians identify their most at-risk patients and aid in developing targeted therapies to prevent progression to diabetes, researchers report.
Glucagon to treat severe hypoglycemia is available in a generic formula for the first time in 20 years.
Researchers urge priority vaccination for individuals with diabetes … AstraZeneca vaccine approval iffy in U.S. with current data, OWS scientist says … WHO trial finds no benefit of 4 drugs for hospitalized COVID patients … COVID antiviral pill trials move forward, long-term care component added … Interactive tool helps find your place in line for…
The Mediterranean diet reduces diabetes risk by 30% in women who are considered clinically overweight or obese, a new analysis of long-term data finds.
A few pounds of weight loss nearly halves diabetes risk, large-scale study finds … FDA: Only N95s are nearly 100% effective, but cloth masks also protective … Link between gut microbiome and risk of Alzheimer’s brain plaques confirmed … Long-term study finds walnut consumption may reduce heart disease risk … Heart failure drug succeeds in…
Dual treatment with the glucose-lowering drugs dapagliflozin and exenatide remains effective for patients with diabetes after two years of continual use, according to the results of a late-stage clinical trial.
A study involving hundreds of Veterans Affairs patients shows a link between the diabetes drug metformin and a lower risk of death from COVID-19.
Nursing homes residents who use continuous glucose monitors (CGMs) to track their daily blood sugar levels would see their Medicare coverage and payments for the devices expanded under a new proposed rule by the federal government. The Centers for Medicare & Medicaid Services on Tuesday announced a proposal for several new changes to Medicare Durable…